TNFRSF1B and breast cancer: Indeed, TNFR2+ T-regs, TNFR2+ B-regs, and TNFR2+ MDCSs all seem to be able to reciprocally activate one another, releasing a variety of immunological mediators, thus inducing a highly immunosuppressive TME, supportive of BC proliferation and development.